Cargando…

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease

We investigated the mechanism of action, safety, and efficacy of the Site-Specific Immunomodulator (SSI) QBECO, a novel immunotherapy for Crohn's disease (CD). Using human monocytic THP-1 cells, we demonstrate that SSI QBECO (derived from the common colon bacteria E. coli) activates macrophages...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bressler, Brian, Bethel, Kevin P., Kleef, Ralf, Reynolds, Sophie L., Sutcliffe, Simon, Mullins, David W., Gunn, Hal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443884/ https://www.ncbi.nlm.nih.gov/pubmed/26064087 http://dx.doi.org/10.1155/2015/231243

Ejemplares similares

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
por: Sutcliffe, Simon, et al.
Publicado: (2019)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)

Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease
por: Pavlidis, Polychronis, et al.
Publicado: (2012)

Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
por: Kwak, Min Seob, et al.
Publicado: (2014)

Effects of Canned Pineapple Consumption on Nutritional Status, Immunomodulation, and Physical Health of Selected School Children
por: Cervo, Mavil May C., et al.
Publicado: (2014)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial
por: Klatte, T, et al.
Publicado: (2006)

Effect of Selective Serotonin Reuptake Inhibitors and Immunomodulator on Cytokines Levels: An Alternative Therapy for Patients with Major Depressive Disorder
por: Hernandez, María Eugenia, et al.
Publicado: (2013)

Nicotine Enemas for Active Crohn's Colitis: An Open Pilot Study
por: Ingram, J. R., et al.
Publicado: (2008)

DNase1: No Association with Crohn's Disease in a New Zealand Population
por: Morgan, Angharad R., et al.
Publicado: (2012)

Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease
por: Sakatani, Aki, et al.
Publicado: (2013)

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
por: Medrano, Luz María, et al.
Publicado: (2015)

Association Analysis of ULK1 with Crohn's Disease in a New Zealand Population
por: Morgan, Angharad R., et al.
Publicado: (2012)

Utility of Computed Tomographic Enteroclysis/Enterography for the Assessment of Mucosal Healing in Crohn's Disease
por: Hashimoto, Shinichi, et al.
Publicado: (2013)

Characteristics of Pediatric Crohn's Disease in Saudi Children: A Multicenter National Study
por: Saadah, Omar I., et al.
Publicado: (2016)

Infliximab Combined with Enteral Nutrition for Managing Crohn's Disease Complicated with Intestinal Fistulas
por: Wu, Xiao-Li, et al.
Publicado: (2016)

Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease
por: Luo, Youyou, et al.
Publicado: (2017)

Small-Bowel Capsule Endoscopy in Patients with Suspected Crohn's Disease—Diagnostic Value and Complications
por: Figueiredo, Pedro, et al.
Publicado: (2010)

Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn's Disease
por: Çekiç, Cem, et al.
Publicado: (2015)

Preoperative Nutritional Therapy Reduces the Risk of Anastomotic Leakage in Patients with Crohn's Disease Requiring Resections
por: Guo, Zhen, et al.
Publicado: (2016)

Maintenance of Remission with Partial Enteral Nutrition Therapy in Pediatric Crohn's Disease: A Retrospective Study
por: Schulman, Jacqueline M., et al.
Publicado: (2017)

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia
por: Ooi, Choon Jin, et al.
Publicado: (2019)

The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease: A Review of Practice at NHS Teaching Hospital
por: Krupa, Lukasz Z., et al.
Publicado: (2011)

Serum Levels of Lipopolysaccharide and 1,3-β-D-Glucan Refer to the Severity in Patients with Crohn's Disease
por: Guo, Yanmin, et al.
Publicado: (2015)

Geographic Mapping of Crohn's Disease and Its Relation to Affluence in Jiangsu Province, an Eastern Coastal Province of China
por: Hu, Dong, et al.
Publicado: (2014)

Co-aggregation and heritability of organ-specific autoimmunity: a population-based twin study
por: Skov, Jakob, et al.
Publicado: (2020)

An Evil Backstage Manipulator: Psychological Factors Correlated with Health-Related Quality of Life in Chinese Patients with Crohn's Disease
por: Liu, Song, et al.
Publicado: (2013)

Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
por: Mizoshita, Tsutomu, et al.
Publicado: (2014)

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study
por: Domachevsky, Liran, et al.
Publicado: (2017)

Pulmonary cryptococcosis after immunomodulator treatment in patients with Crohn’s disease: Three case reports
por: Fang, Yan-Fei, et al.
Publicado: (2023)

Novel Closing Method Using Subcutaneous Continuous Drain for Preventing Surgical Site Infections in Radical Cystectomy
por: Hirose, Yasuhiko, et al.
Publicado: (2014)

In Crohn's Disease, Anti-TNF-α Treatment Changes the Balance between Mucosal IL-17, FOXP3, and CD4 Cells
por: Hölttä, Veera, et al.
Publicado: (2012)

The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn's Disease: Experience from a Tertiary Medical Center in China
por: Zhang, Tianyu, et al.
Publicado: (2016)

Magnetic Resonance Enterography and Capsule Endoscopy in Patients Undergoing Patency Capsule for the Evaluation of Small Bowel Crohn's Disease: A Korean Clinical Experience
por: Lee, Hyun Seok, et al.
Publicado: (2020)

Melatonin as an immunomodulator in children with Down syndrome
por: Huggard, Dean, et al.
Publicado: (2021)

Curcumin Ameliorates Ischemia-Induced Limb Injury Through Immunomodulation
por: Liu, Yang, et al.
Publicado: (2016)

Small Bowel Adenocarcinoma in a Patient with Crohn's Disease: The Role of Balloon-Assisted Enteroscopy
por: Dias, Emanuel, et al.
Publicado: (2022)

Infliximab Preferentially Induces Clinical Remission and Mucosal Healing in Short Course Crohn's Disease with Luminal Lesions through Balancing Abnormal Immune Response in Gut Mucosa
por: Yu, Lijuan, et al.
Publicado: (2015)

Biologic monotherapy versus combination therapy with immunomodulators in the induction and maintenance of remission of Crohn’s disease and ulcerative colitis
por: Hashash, Jana G., et al.
Publicado: (2021)

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease
por: Panaccione, Remo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s638hkjmf3i8rotdu9me7buq9q